Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001415889-25-001242

PRESIDENT AND CEO sold 17,500 shares at an average $41.74 ($730,535)

  • PRESIDENT AND CEO acquired 17,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Fordyce Marshall · PRESIDENT AND CEO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-08 Exercise or conversion : show line 1 in the form 10b5-1 +9,975 $2.90 $28,896 153,578 D
2025-01-08 Sale : show line 2 in the form 10b5-1 −9,975 $41.53 $414,297 143,603 D
2025-01-08 Exercise or conversion : show line 3 in the form 10b5-1 +5,650 $2.90 $16,367 149,253 D
2025-01-08 Sale : show line 4 in the form 10b5-1 −5,650 $42.03 $237,489 143,603 D
2025-01-08 Exercise or conversion : show line 5 in the form 10b5-1 +1,875 $2.90 $5,432 145,478 D
2025-01-08 Sale : show line 6 in the form 10b5-1 −1,875 $42.00 $78,750 143,603 D
Open-market sales · 17,500 sh · avg $41.74 · $730,535

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-01-08 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) −15,625 610,926 D
2025-01-08 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) −1,875 609,051 D
Loading xslF345X05/form4-01102025_090146.xml…